Steward Partners Investment Advisory’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,641
| Closed | -$301K | – | 3480 |
|
|
2021
Q2 | $301K | Buy |
1,641
+149
| +10% | +$27.3K | 0.01% | 1184 |
|
|
2021
Q1 | $228K | Sell |
1,492
-17
| -1% | -$2.6K | ﹤0.01% | 1234 |
|
|
2020
Q4 | $236K | Sell |
1,509
-783
| -34% | -$122K | 0.01% | 1003 |
|
|
2020
Q3 | $262K | Buy |
2,292
+481
| +27% | +$55K | 0.01% | 851 |
|
|
2020
Q2 | $203K | Buy |
1,811
+152
| +9% | +$17K | 0.01% | 880 |
|
|
2020
Q1 | $148K | Buy |
1,659
+738
| +80% | +$65.8K | 0.01% | 877 |
|
|
2019
Q4 | $99K | Buy |
921
+757
| +462% | +$81.4K | ﹤0.01% | 1142 |
|
|
2019
Q3 | $16K | Sell |
164
-52
| -24% | -$5.07K | ﹤0.01% | 1820 |
|
|
2019
Q2 | $28K | Buy |
+216
| New | +$28K | ﹤0.01% | 1581 |
|
|
2018
Q4 | – | Sell |
-312
| Closed | -$43K | – | 2423 |
|
|
2018
Q3 | $43K | Sell |
312
-197
| -39% | -$27.2K | ﹤0.01% | 1269 |
|
|
2018
Q2 | $63K | Sell |
509
-211
| -29% | -$26.1K | ﹤0.01% | 1010 |
|
|
2018
Q1 | $80K | Sell |
720
-720
| -50% | -$80K | 0.01% | 840 |
|
|
2017
Q4 | $172K | Sell |
1,440
-519
| -26% | -$62K | 0.01% | 547 |
|
|
2017
Q3 | $274K | Buy |
1,959
+130
| +7% | +$18.2K | 0.03% | 384 |
|
|
2017
Q2 | $222K | Buy |
1,829
+355
| +24% | +$43.1K | 0.02% | 386 |
|
|
2017
Q1 | $178K | Buy |
1,474
+1,217
| +474% | +$147K | 0.03% | 339 |
|
|
2016
Q4 | $31K | Buy |
+257
| New | +$31K | 0.01% | 397 |
|